IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 242 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,162,750 | -5.2% | 2,924,123 | +4.7% | 0.00% | 0.0% |
| Q2 2023 | $29,709,922 | +7.2% | 2,792,285 | +6.0% | 0.00% | -25.0% |
| Q1 2023 | $27,707,629 | +88809.1% | 2,633,804 | +4.7% | 0.00% | 0.0% |
| Q4 2022 | $31,164 | -99.9% | 2,515,290 | +2.0% | 0.00% | 0.0% |
| Q3 2022 | $25,543,000 | -15.3% | 2,465,627 | -5.7% | 0.00% | 0.0% |
| Q2 2022 | $30,151,000 | -13.1% | 2,615,039 | -5.2% | 0.00% | 0.0% |
| Q1 2022 | $34,704,000 | +7.7% | 2,758,736 | -0.2% | 0.00% | 0.0% |
| Q4 2021 | $32,223,000 | -12.2% | 2,763,568 | -1.7% | 0.00% | -20.0% |
| Q3 2021 | $36,716,000 | +3.5% | 2,811,404 | +2.0% | 0.01% | 0.0% |
| Q2 2021 | $35,487,000 | +14.3% | 2,757,409 | -0.7% | 0.01% | 0.0% |
| Q1 2021 | $31,039,000 | +10.1% | 2,776,343 | +12.2% | 0.01% | 0.0% |
| Q4 2020 | $28,181,000 | +32.9% | 2,474,244 | +5.0% | 0.01% | +25.0% |
| Q3 2020 | $21,204,000 | -15.0% | 2,357,467 | -2.5% | 0.00% | -20.0% |
| Q2 2020 | $24,944,000 | +7.8% | 2,417,077 | +5.4% | 0.01% | -16.7% |
| Q1 2020 | $23,132,000 | -60.4% | 2,292,646 | -47.8% | 0.01% | 0.0% |
| Q4 2019 | $58,406,000 | +214.8% | 4,388,176 | +103.1% | 0.01% | +50.0% |
| Q3 2019 | $18,552,000 | -20.2% | 2,161,004 | +1.7% | 0.00% | -33.3% |
| Q2 2019 | $23,237,000 | -11.6% | 2,124,100 | +9.4% | 0.01% | -14.3% |
| Q1 2019 | $26,274,000 | -23.6% | 1,941,979 | -41.5% | 0.01% | +40.0% |
| Q4 2018 | $34,368,000 | +19.0% | 3,317,508 | +112.1% | 0.01% | -37.5% |
| Q3 2018 | $28,876,000 | +6.1% | 1,564,301 | +9.9% | 0.01% | 0.0% |
| Q2 2018 | $27,222,000 | +37.5% | 1,423,792 | +11.0% | 0.01% | +33.3% |
| Q1 2018 | $19,792,000 | +6.5% | 1,282,719 | +3.5% | 0.01% | 0.0% |
| Q4 2017 | $18,586,000 | -2.5% | 1,239,906 | +2.6% | 0.01% | -14.3% |
| Q3 2017 | $19,066,000 | -15.5% | 1,209,005 | +1.2% | 0.01% | -22.2% |
| Q2 2017 | $22,560,000 | +15.1% | 1,194,961 | +4.0% | 0.01% | +12.5% |
| Q1 2017 | $19,605,000 | +23.0% | 1,149,205 | +10.3% | 0.01% | +14.3% |
| Q4 2016 | $15,935,000 | +1.6% | 1,042,193 | +5.5% | 0.01% | -12.5% |
| Q3 2016 | $15,686,000 | +25.8% | 987,867 | +3.5% | 0.01% | +14.3% |
| Q2 2016 | $12,473,000 | +22.2% | 954,033 | +2.3% | 0.01% | +40.0% |
| Q1 2016 | $10,204,000 | +0.7% | 932,729 | +6.6% | 0.01% | -16.7% |
| Q4 2015 | $10,136,000 | +17.4% | 874,584 | +5.5% | 0.01% | +20.0% |
| Q3 2015 | $8,636,000 | -7.0% | 828,822 | +7.6% | 0.01% | 0.0% |
| Q2 2015 | $9,288,000 | -23.1% | 770,255 | +2.1% | 0.01% | -28.6% |
| Q1 2015 | $12,073,000 | +10.1% | 754,644 | +5.4% | 0.01% | 0.0% |
| Q4 2014 | $10,967,000 | +21.2% | 715,886 | +2.5% | 0.01% | +16.7% |
| Q3 2014 | $9,046,000 | -14.7% | 698,339 | +1.0% | 0.01% | -14.3% |
| Q2 2014 | $10,600,000 | +29.8% | 691,472 | +4.3% | 0.01% | +40.0% |
| Q1 2014 | $8,169,000 | +36.9% | 663,089 | +29.0% | 0.01% | +25.0% |
| Q4 2013 | $5,965,000 | +7.7% | 513,860 | +10.0% | 0.00% | 0.0% |
| Q3 2013 | $5,538,000 | +35.6% | 467,321 | +13.9% | 0.00% | 0.0% |
| Q2 2013 | $4,083,000 | – | 410,375 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |